Clinical trials
Withdrawn Phase 2 Alzheimer Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
16 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 1 |
| 2021 | 1 |
| 2023 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 16 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Botanicure Co., Ltd. | 1 |
| Brendan Lucey | 1 |
| CERESPIR | 1 |
| Chase Pharmaceuticals Corporation, an affiliate of Allergan plc | 1 |
| Columbia University | 1 |
| Department of Medical Services Ministry of Public Health of Thailand | 1 |
| FORUM Pharmaceuticals Inc | 1 |
| GemVax & Kael | 1 |
| Inmune Bio, Inc. | 1 |
| Massachusetts General Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alzheimer Disease | 16 |
| Dementia | 6 |
| Cognitive Dysfunction | 5 |
| Neurodegenerative Diseases | 3 |
| Brain Diseases | 2 |
| Central Nervous System Diseases | 2 |
| Tauopathies | 2 |
| Dementia, Vascular | 1 |
| Diabetes Mellitus | 1 |
| Inflammation | 1 |
Trials
Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.